Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

ZBH Financials

SEC Filings

ZBH Quarterly Income Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
8.409B2.087B2.244B2.001B2.077B1.909B2.023B1.824B1.942B
Cost of Goods Sold
2.520B576.200M792.400M559.300M592.200M549.800M586.700M538.600M553.600M
5.889B1.510B1.451B1.442B1.485B1.359B1.437B1.286B1.388B
72.4%72.4%64.7%72.1%71.5%71.2%71.0%70.5%71.5%
Total Operating Expenses
4.577B1.137B1.164B1.091B1.185B1.067B1.048B1.006B1.037B
451.400M103.400M118.800M115.900M113.300M110.600M108.500M111.600M109.400M
3.343B849.900M867.100M811.400M814.800M758.800M746.900M709.700M737.100M
1.312B373.200M287.800M351.300M300.000M292.300M389.000M279.500M351.300M
17.9%17.9%12.8%17.6%14.4%15.3%19.2%15.3%18.1%
903.100M301.300M98.000M279.200M224.600M229.000M289.000M230.300M302.200M
Interest Income
295.400M68.800M71.900M75.400M79.300M66.200M61.900M54.300M51.100M
Other Income/Expense
-409.200M-71.900M-189.800M-72.100M-75.400M-63.300M-100.000M-49.200M-49.100M
761.300M238.100M139.500M230.900M152.800M182.000M239.500M249.100M242.800M
142.300M63.000M-39.900M48.000M71.200M46.500M48.900M-18.900M59.100M
11.4%11.4%6.2%11.5%7.4%9.5%11.8%13.7%12.5%
2.206B538.300M453.900M638.200M575.700M549.600M614.500M535.500M596.500M
25.8%25.8%20.2%31.9%27.7%28.8%30.4%29.4%30.7%
1.002B162.100M284.000M283.600M271.800M254.400M263.600M250.900M243.200M
3.871.220.711.170.770.921.201.231.18
3.851.220.701.160.770.911.201.231.18
195.000M195.000M197.200M198.100M197.900M198.900M199.100M202.300M205.700M
195.800M195.800M198.100M198.800M198.300M199.700M199.900M203.000M206.400M

ZBH Annual Income Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
8.232B7.679B7.394B6.940B6.827B6.128B7.982B7.933B
Cost of Goods Sold
3.160B2.191B2.084B2.019B1.960B1.824B2.253B2.272B
5.072B5.487B5.310B4.920B4.867B4.303B5.730B5.661B
61.6%71.5%71.8%70.9%71.3%70.2%71.8%71.4%
Total Operating Expenses
3.710B4.202B4.033B4.224B4.007B4.220B4.592B5.627B
458.500M437.400M458.700M406.000M435.800M322.800M449.300M391.700M
3.251B2.930B2.839B2.762B2.843B2.713B3.344B3.379B
1.362B1.286B1.278B696.300M860.300M83.100M1.137B33.800M
16.5%16.7%17.3%10.0%12.6%1.4%14.3%0.4%
830.800M1.037B1.067B403.500M499.000M-105.200M905.800M-271.100M
Interest Income
292.800M218.000M201.200M164.800M208.400M212.100M226.900M289.300M
Other Income/Expense
-531.400M-249.100M-210.400M-292.800M-361.300M-188.300M-231.700M-304.900M
705.200M903.800M1.024B231.400M401.600M-138.900M1.132B-379.200M
125.700M131.400M42.200M112.300M53.500M-96.000M-225.700M108.200M
8.6%11.8%13.8%3.3%5.9%-2.3%14.2%-4.8%
2.217B2.251B2.220B1.495B1.645B1.005B2.139B1.059B
26.9%29.3%30.0%21.5%24.1%16.4%26.8%13.3%
1.094B996.300M951.700M926.400M937.700M898.400M1.006B1.040B
3.564.454.911.101.93-0.675.52-1.86
3.554.434.881.101.91-0.675.47-1.86
198.000M203.100M208.700M209.600M208.600M207.000M205.100M203.500M
198.700M203.900M209.700M210.300M210.400M207.000M206.700M203.500M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos